newsfilter
← Latest News
Business Wire·

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

Twist to retain all upfront, service and other revenue earned under antibody discovery and biopharma solutions agreements as well as half of future milestones and royalties Twist Bioscience Corporation (NASDAQ:TWST), a